You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 017386


✉ Email this page to a colleague

« Back to Dashboard


NDA 017386 describes ZAROXOLYN, which is a drug marketed by I3 Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the ZAROXOLYN profile page.

The generic ingredient in ZAROXOLYN is metolazone. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the metolazone profile page.
Summary for 017386
Tradename:ZAROXOLYN
Applicant:I3 Pharms
Ingredient:metolazone
Patents:0
Medical Subject Heading (MeSH) Categories for 017386
Suppliers and Packaging for NDA: 017386
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZAROXOLYN metolazone TABLET;ORAL 017386 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 43353-999 43353-999-09 9000 TABLET in 1 BOTTLE, PLASTIC (43353-999-09)
ZAROXOLYN metolazone TABLET;ORAL 017386 NDA AUTHORIZED GENERIC Aphena Pharma Solutions - Tennessee, LLC 71610-142 71610-142-09 9000 TABLET in 1 BOTTLE, PLASTIC (71610-142-09)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.